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Identifying and analyzing macromolecular processes such as protein-protein interactions and
conformational dynamics are central to chemical biology, biochemistry and medicine.
Fluorescence-based sensors are important tools for monitoring these processes. The majority
of sensors rely on Förster Resonance Energy Transfer (FRET), which takes advantage of the
distance-dependent interaction of two fluorophores to report proximity or/and changes in the
fluorophore dipolar interactions. FRET has been extensively used to explore spatiotemporal
regulation of various biochemical phenomena.[1] The design of FRET-based systems
involves strategic positioning of two fluorophores to maximize signal changes enabling the
researcher to monitor biological events. Ideally, the FRET-based assays lead to a decrease in
the donor emission and an increase of the acceptor emission, allowing FRET processes to be
followed by ratiometric measurements. Fluorescent labels can either be fused to two
interacting partners to report molecular assembly (intermolecular FRET) or tagged on the
same protein to report conformational changes (intramolecular FRET). The integration of
fluorescent probes into protein is widespread and often pairs of genetically encoded
autofluorescent proteins (FPs) such as the GFP variants CFP/YFP, as donor and acceptor
fluorophores, are applied.[2] In general, acceptable changes in emission intensities using
intramolecular FRET can only be achieved by considerable experimentation with different
constructs and often, the signal to background ratios are small due to high background
fluorescence. Also, the size (~27 kDa) of the FPs may perturb protein localization and
complicate FRET analyses.[3]
Alternatively, approaches where synthetic fluorophores are attached to target proteins via
self-labeling protein tags such as the the SNAP-tag,[4] CLIP-tag,[5] or Halo-tag[6] have
proven to be valuable. In this case, the range of synthetic fluorophores that can be recruited
is considerable. However, one limitation of these systems is high fluorescence background
signal due to the presence of unreacted probes and non-specific binding. Therefore washing
steps may be necessary which are not always possible, for example in the real-time
measurement of binding events. In this context, useful approaches for reducing background
fluorescence have recently been reported.[7] In general, FRET-based approaches necessitate
considerable inter- or intramolecular distance modulation to observe useful changes in
fluorescence. While in some cases the target systems can be engineered to enhance spectral
changes, for example in the recent development of a carbonic anhydrase-based FRET
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system for sensing benzenesulfonamide,[8] there remains the opportunity for new
experimental approaches for measuring dynamic protein interactions and conformational
changes.
Herein, we present the design, development and validation of an alternative FRET approach
that exploits a solvatochromic fluorophore as a FRET donor. This approach addresses some
of the shortcomings of traditional FRET-based experiments. In this context we note that
methods for investigating the sequence specific recognition of DNA, by exploiting
intercalated environment-sensitive fluorophores as FRET donors have been reported.[9]
Solvatochromic fluorophores like dimethylamino-naphthalimides (DMNs) and
dimethylaminophthalimides (DMPs) are sensitive to the local environment and exhibit
extremly weak fluorescence in polar protic environments conferring the advantage of low
background signals until the occurrence of an event that alters the local environment around
the fluorophore. These dyes have been successfully applied in various contexts.[10]
Recently, we introduced an amino acid based on the solvatochromic fluorophore 4-N,N-
dimethylamino-1,8-naphthalimide (4DMN) for sensing binding of M13 (the calmodulin
(CaM)-binding peptide)[11] to Ca2+-activated CaM with a fluorescence increase of up to
100-fold.[12] 4DMN has been applied for studying the dynamic interactions of CaM in the
apo-state and in the Ca2+-bound form.[13] Taking a cue from these studies, we envisioned a
fluorescence-based approach, termed FRET-CAPTURE, which would combine
solvatochromic fluorescence to “turn-on” a donor fluorophore for energy transfer to an
acceptor fluorophore thereby exploiting the high apparent Stokes shift of a FRET
experiment. A key feature of this method is that in polar protic solvents such as water, the
solvatochromic FRET donors in the DMN family are completely non-emissive and therefore
background levels of energy transfer are totally absent. In contrast, solvatochromic
fluorophores such as BADAN and NBD show background fluorescence in water and when
attached to the M13 peptide,[11] which would induce an increased FRET signal even in the
unbound state. Therefore, the FRET-CAPTURE approach is unique to solvatochromic
fluorophores that show a completely non-emissive state. Additionally, in FRET-CAPTURE
a conformational change is not necessary and an extra level of specificity is added to the
readout since the donor fluorescence is only initiated after target binding. Additionally,
while the maximal emission wavelength of 4DMN (~ 505 nm) is in a range where cellular
background fluorescence can interfere, the FRET process shifts the emission to more
advantageous wavelengths.
Here, we exploit the CaM system for establishing the concepts and potential of the new
methodology. Specifically, 4DMN was introduced into the M13 peptide as a fluorescence
donor and a second carefully chosen non-solvatochromic fluorophore was attached to the
CaM to serve as a FRET acceptor (Fig. 1A) to study the intermolecular modality of FRET-
CAPTURE. In general, FRET is dependent on the donor/acceptor distance, the relative
orientation of the donor and acceptor transition dipole moments, and the overlap between
donor emission and acceptor absorbance. Therefore, several fluorophores, displaying
significant spectral overlap with 4DMN, were surveyed at different acceptor positions in the
CaM protein to define combinations with optimal FRET efficiency and high fluorescence
increases. We also demonstrate an intramolecular FRET-CAPTURE approach using dual
labeling of the M13 peptide with both 4DMN and an acceptor fluorophore. The latter
approach is illustrated using micropatterning the CaM/M13 peptide interaction on glass
surfaces. In this case, an intramolecular FRET-CAPTURE signal is observed even in the
absence of any change in the interfluorophore distance.
The M13 peptide was synthesized as described previously,[12] and 4DMN was introduced as
the Fmoc-protected amino acid (4DMN-A) at position 8 of the native M13 sequence.
Fluorescent labeling with the acceptor dye was performed using the CaM cysteine mutants
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E11C, M76C and M145C (Figure 1B) enabling selective labeling of the protein with thiol-
reactive reagents.
We first explored the influence of the CaM labeling site on the increase of 4DMN
fluorescence alone (Fig. S1). Binding of the 4DMN-labeled M13 peptide to the Ca2+-
activated CaM mutants resulted in varying degrees of fluorescence enhancement. The
complexes were analyzed by measuring the ratio of fluorescence intensity at the emission
maximum of 4DMN (λmax = 505 nm) in the Ca2+-CaM bound complex to the fluorescence
intensity of the apo-state in the presence of the 4DMN-labeled M13 mutant. The 4DMN
fluorescence increase achieves the highest value of 180-fold in the M76C CaM mutant
complex followed by 98-fold and 43-fold in the E11C and M145C CaM mutant complexes,
respectively. Concurrent with the increase in fluorescence intensity was a hypsochromic
shift in the emission maximum from 535 nm in the apo-state to 505 nm in the Ca2+-bound
state. The differences in 4DMN fluorescence resulting from these mutants are attributed to
variations in the hydrophobic environment of the fluorophore upon binding.
Next, we investigated the effect of incorporating six potential FRET acceptor fluorophores
(Alexa Fluor 555, Alexa Fluor 568, Alexa Fluor 594, Alexa Fluor 633, BODIPY®-TMR
and BODIPY®-577) into each of the three cysteine mutants of CaM. Representative FRET-
CAPTURE data for the E11C CaM mutant, which is labeled using Alexa Fluor® dyes with
varying excitation wavelengths is shown in Fig. 2 (See SI for the complete data set).
Fluorescence spectra were recorded upon donor excitation for (1) the acceptor-only labeled
CaM in the apo-state; (2) CaM in the Ca2+-bound state; (3) CaM in the presence of 4DMN-
labled M13 peptide in the apo-state; (4) CaM in the Ca2+-bound state with the 4-DMN-
labeled M13 (Fig. 2). The acceptor dyes showing the largest spectral overlap are Alexa
Fluor 555 (Fig. 2A) and BODIPY®-TMR (Fig. S2E). However, the fluorescence response
of the Alexa Fluor 555-labeled calmodulin mutant alone was negligible after excitation of
the donor absorbance in the apo- and in the Ca2+-bound-state. Importantly, in the absence of
Ca2+, the dual labeled system showed a similar negligible fluorescence emission upon
excitation at 395 nm. However, formation of the structured Ca2+-bound complex resulted in
a fluorescence increase due to FRET from the bound 4DMN and was accompanied by a shift
of the fluorescence emission maximum from 505 nm to 570 nm compared to the 4DMN
only labeled system. The FRET signal shows robust 23-fold fluorescence increase. Also
illustrated (Fig. 2) are fluorescence studies with Alexa Fluor 594 and Alexa Fluor 633-
modified E11C CaM. Upon addition of the 4DMN-M13 peptide, the Alexa 594 construct
showed a modest 5.5-fold increase in fluorescence at 611 nm due to FRET-CAPTURE. In
addition, the direct fluorescence emission from 4DMN increased 113.7-fold. There was no
acceptor fluorescence increase for Alexa Fluor 633, which is the dye with the smallest
spectral overlap with CaM-bound 4DMN. The main emission signal that is observed results
from the donor fluorescence and the acceptor signal is about 3.4-fold smaller.
We also explored the fluorescence response of the M76C and M145C acceptor-labeled
calmodulin mutants (Fig. S3 and S4). The donor and FRET-fluorescence increases for the
three mutants with Alexa Fluors 555, 594 and 633 are summarized in Fig. 3. The overall
observation was that the 4DMN/Alexa Fluor 555 pair demonstrated the highest FRET
fluorescence increase (23.4–25.1-fold). Interestingly the fluorescence increases did not vary
greatly amongst the three mutants, due to the fact that the interfluorophore distance was
relatively small and in a range where FRET efficiency would be insensitive to distance (≪
Ro, for estimation of Ro see SI). We note that the NMR structure of CaM bound to M13
(PDB: 2BBM) shows that the C-α site of M145, M76, and E11 is approximately 9 Å, 21 Å,
12 Å away from the 8 position of the M13 peptide.
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A comparison of the fluorescence background intensity of the acceptor only-labeled CaM
reveals no change in emission with addition of Ca2+. For detection of protein interactions in
complex environments it would be reasonable to subtract the background (FBG-Ca2+ and
FBG-EGTA) first before dividing the intensity of the bound-state by the intensity of the apo-
state. The resulting background-corrected FRET fluorescence increase [(FFRET −
FBG)Ca2+/(FFRET − FBG)EGTA] is shown in Figs. 3B,D,F (dark grey bars). With this
analysis an average fluorescence increase of ~11.3-fold for Alexa Fluor 594 acceptor dyes
would be observed, while no significant change in the FRET fluorescence increase would be
observed for the Alexa Fluor 555 since the background fluorescence of Alexa Fluor 555 is
low enough that the signal does not interfere with the FRET measurement. Background
correction of the Alexa Fluor 633 signal increases the average FRET fluorescence
enhancement from 1.7-fold to 3.5-fold. This analysis reveals opportunities for applications
that involve multplexing since the FRET-CAPTURE from bound 4DMN to spectrally
distinguishable FRET acceptors could potentially be observed.
We also investigated intramolecular FRET-CAPTURE by observing the effect of dual
labeling of the M13 peptide. In this case, the environment-sensitive donor dye 4DMN was
retained at position 8 (M13 peptide) and the acceptor fluorophore was incorporated at the N-
terminus of the peptide by using cysteine modification chemistry. The fluorescence
spectrum of the donor-only labeled M13 peptide, with an additional N-terminal cysteine,
revealed a 41-fold fluorescence change from the unbound to the protein bound state (Fig.
S5). We then evaluated the three acceptor dyes Alexa Fluor 555, Alexa Fluor 568, and
Alexa Fluor 594 that demonstrated good fluorescence increases in the intermolecular FRET-
CAPTURE experiments and also gave high labeling efficiencies. The 4DMN/Alexa 555 pair
demonstrated the best performance (Fig. 4A and S6). The fluorescence signal of the
unbound 4DMN/Alexa 555-labeled M13 peptide showed a minimal background acceptor
emission spectrum in the presence of CaM. After Ca2+ addition, a significant 4.9-fold
increase in the acceptor fluorescence was observed.
A major source of high background in complex biological environments is due to non-
specific binding. To demonstrate the high specificity of the FRET-CAPTURE signal, the
4DMN/Alexa 555-labeled M13 peptide was added to HeLa cell lysates and fluorescence
was measured in the presence and absence of Ca2+ (Fig. 4B). In the absence of Ca2+, no
significant background fluorescence compared to a simple TBS buffered solution was
observed (Fig S8A). In the presence of Ca2+, the dual labeled peptide signaled a low level of
endogenous CaM with a FRET-CAPTURE signal increase of 1.6-fold (60%), which was
stable over time and reversible in the presence of added EGTA (Fig. S8B). Addition of
recombinant CaM increased the FRET-CAPTURE signal increase up to 3.1-fold.
The response of the 4DMN/Alexa Fluor 555 pair made this an optimal system for
investigating whether FRET-CAPTURE was suitable for monitoring binding events on
modified glass surfaces. Proteins and peptides are commonly printed on modified glass
surfaces for applications in biosensing, bioanalysis, as well as small molecule screening.[14]
Creating a FRET-CAPTURE pattern with the CaM/M13 peptide construct demonstrates the
sensitivity of the system to fluoresce in a well-defined monolayer bound to a surface. Biotin
surface patterns were obtained by using amino-functionalized glass surfaces, micro-
patterned with PDMS-stamps inked in NHS-PEG-biotin, to define binding sites. The
remaining functional groups on the surface were blocked using NHS-PEG8. Streptavidin
was attached to the biotin-patterned substrates followed by biotinylated CaM (E11C mutant)
to create a CaM pattern (Fig. 4C). In the last step, the 4DMN/Alexa Fluor 555 labeled M13
peptide was brought in contact with CaM in a buffer containing Ca2+ and a FRET-
CAPTURE pattern was monitored using confocal microscopy. The imaging revealed both
the 4DMN (green) and the FRET- (red) emission with a strong fluorescence contrast
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between the background and the stamped regions (Fig 4D). In the negative control the
4DMN/Alexa Fluor 555 labeled M13 peptide was added to the CaM pattern in a buffer
without Ca2+ (Fig. 4E). While background fluorescence was visible, the unbound state
could be clearly discriminated from the bound state. In a further control, the addition of
CaM was omitted, demonstrating that the fluorescence signal is attributed only to the
specific binding (Fig. S9C). A pattern produced with the 4DMN-only labeled M13 peptide
(Fig. S9D) revealed only sharp features in the emission range of the donor.
In summary, we have presented the principles of inter- and intramolecular FRET-
CAPTURE to signal protein interactions and conformational changes by exploiting the
unique donor fluorescence of a bound solvatochromic dye (4DMN) coupled with selected
acceptor fluorophores, which afford an advantageous bathochromic shift of the emission
wavelength. The method has been demonstrated to be useful in simple buffer systems,
unfractionated cell lysates and on micro-patterned glass surfaces. The detected 20–30-fold
FRET-fluorescence increases achieved by applying the 4DMN/Alexa 555 pair compares
favourably with reported FRET-enhancements for protein sensing. The background
fluorescence, depending on the FRET acceptor is either negligible or very low, and no
washing steps are necessary to remove unbound or non-specific bound probes. A unique
feature of the presented FRET-CAPTURE method is the additional level of signal selectivity
since the FRET signal is only turned on when the donor is specifically bound to the protein
of interest, eliminating false positive results. The probes provide two readout modes after
donor excitation to detect protein-interactions: I) Donor emission at 505 nm and II) FRET-
CAPTURE emission depending on the acceptor from 570 – 644 nm, revealing a high
apparent Stokes shift of more than 170 nm. The ability to apply acceptor fluorophores with
unique emission properties further suggests that the method could be expanded to include
the simultaneous application of two suitable FRET-pairs, which would enable multiplexing.
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Figure 1.
A) FRET-CAPTURE for sensing the Ca2 + induced interaction between CaM and the M13
peptide. The M13 peptide mutant (blue) contains the solvatochromic fluorophore 4DMN as
an amino acid building block (green) that signals binding of the M13 peptide to the Ca2 +
activated CaM (grey) to an acceptor dye (red) attached to CaM by FRET. B) The positions
of the acceptor in the three different cysteine mutants are marked in red in the NMR
structure of the Ca2 +-CaM-M13 peptide complex (PDB: 2BBM).
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Figure 2.
Fluorescence measurements after 4DMN excitation in the acceptor only labeled E11C CaM
mutant (black) and in the dual-labeled E11C CaM Acceptor mutant/M134DMN peptide
construct (red) in the absence (dashed line) and presence (solid line) of Ca2 +. Acceptor = A)
Alexa555, B) Alexa594, and C) Alexa633. Conditions: 400 nM CaM, 400 nM M134DMN,
200 μM CaCl 2, 40 μM EGTA in TBS, 25°C, pH = 7.4, λEx * = A) 395 nm; B) + C) 435 nm;
slitEx 10 nm, slitEm 5 nm. (*Different excitation wavelengths are used according to
minimize donor-independent fluorescence.)
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Figure 3.
Signal to background ratios: Right panels demonstrate donor fluorescence increases and left
panels show FRET fluorescence increases. A) and B) E11C CaM mutant/M13 peptide; C)
and D) M76C CaM mutant/M13 peptide and E) and F) M145C CaM mutant/M13 peptide.
FD is the donor fluorescence at 505 nm, FFRE T is the FRET fluorescence, and FBG is the
fluorescence of only acceptor labeled CaM (Background). FFRET and FBG are measured at
the acceptor emission maximum. (Conditions: see Figure 2).
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Figure 4.
Measurement of intramolecular FRET-CAPTURE using the 4DMN/Alexa555-labeled M13
peptide A) in the presence of the E11C CaM mutant in the apo state (dashed lines) and in the
Ca2 +-state (solid line) after excitation of the 4DMN (λEX = 435 nm). (Conditions: 800 nM
CaM E11C, 600 nM M13 in TBS,see Figure 2) and B) in HeLa cell lysates in the presence
and absence Ca2 + before and after adding recombinant CaM. (Conditions: 200 nM M13,
800 nM CaM when added.) C) Scheme of creating a CaM/M134DMN/Alexa555 peptide micro-
pattern which shows fluorescence in the presence of Ca2 + for both, donor and acceptor
fluorophore. D–E) Confocal laser scanning microscopy images of the CaM/M13 peptide
pattern on glass. Dual-labeled Alexa/4DMN-M13 peptide was added to D) Ca2 +-activated
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CaM, or to E) CaM in the apo-state. Images were taken with a confocal laser scanning
microscope at rt and λEx = 458 nm. White bars: 30 μm.
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